NeoGenomics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for NEO, updated each market day.
NEO AI Sentiment
AI predicts NeoGenomics, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Sector
Exchange
Market Cap
$2,555,376,501
Cap Tier
Employees
2,500
Headquarters
FORT MYERS, FL
Listed Since
Jan. 25, 1996
Website
NEO Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NEO Volatility
NeoGenomics, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
